Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Smith Mark Alan Create: Alert

All | News | Filings
Date FiledTypeDescription
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2022 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 2,655 shares @ $1.6575, valued at $4.4k
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2020 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $0.398, valued at $59.7k
10/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2019 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $1, valued at $150k
08/31/2018 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Disposed/sold 180,000 options to buy @ $3.49, valued at $628.2k
Granted 180,000 options to buy @ $1.5, valued at $270k
Disposed/sold 80,000 options to buy @ $3.8, valued at $304k
Granted 80,000 options to buy @ $1.5, valued at $120k
Disposed/sold 125,000 options to buy @ $1.96, valued at $245k
Granted 125,000 options to buy @ $1.5, valued at $187.5k
08/06/2018 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.27, valued at $127k
02/05/2018 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 200,000 options to buy @ $1.16, valued at $232k
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/10/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/21/2016 4 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.
Txns: Granted 180,000 options to buy @ $3.49, valued at $628.2k
06/21/2016 3 Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 3 on VistaGen Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy